|
1
|
Ma CC, Xiong Z, Zhu GN, Wang C, Zong G,
Wang HL, Bian EB and Zhao B: Long non-coding RNA ATB promotes
glioma malignancy by negatively regulating miR-200a. J Exp Clin
Cancer Res. 35:902016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramaswamy V and Taylor MD: CAR T cells for
childhood diffuse midline gliomas. Nat Med. 24:534–535. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tobias A, Ahmed A, Moon KS and Lesniak MS:
The art of gene therapy for glioma: A review of the challenging
road to the bedside. J Neurol Neurosurg Psychiatry. 84:213–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng YJ, Liang TS, Wang J, Zhao JY, Yang
DK and Liu ZS: Silencing lncRNA LOC101928963 inhibits proliferation
and promotes apoptosis in spinal cord glioma cells by binding to
PMAIP1. Mol Ther Nucleic Acids. 18:485–495. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alvi MA, Ida CM, Paolini MA, Kerezoudis P,
Meyer J, Barr Fritcher EG, Goncalves S, Meyer FB, Bydon M and
Raghunathan A: Spinal cord high-grade infiltrating gliomas in
adults: Clinico-pathological and molecular evaluation. Mod Pathol.
32:1236–1243. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ropper AE, Zeng X, Haragopal H, Anderson
JE, Aljuboori Z, Han I, Abd-El-Barr M, Lee HJ, Sidman RL, Snyder
EY, et al: Targeted treatment of experimental spinal cord glioma
with dual gene-engineered human neural stem cells. Neurosurgery.
79:481–491. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
An T, Fan T, Zhang XQ, Liu YF, Huang J,
Liang C, Lv BH, Wang YQ, Zhao XG, Liu JX, et al: Comparison of
alterations in miRNA expression in matched tissue and blood samples
during spinal cord glioma progression. Sci Rep. 9:91692019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gebert LF and MacRae IJ: Regulation of
microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wessels HH, Lebedeva S, Hirsekorn A,
Wurmus R, Akalin A, Mukherjee N and Ohler U: Global identification
of functional microRNA-mRNA interactions in Drosophila. Nat
Commun. 10:16262019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moradimotlagh A, Arefian E, Valojerdi RR,
Ghaemi S, Adegani FJ and Soleimani M: MicroRNA-129 inhibits glioma
cell growth by targeting CDK4, CDK6, and MDM2. Mol Ther Nucleic
Acids. 19:759–764. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu SJ, Hu HT, Li HL and Chang S: The role
of miRNAs in immune cell development, immune cell activation, and
tumor immunity: With a focus on macrophages and natural Killer
cells. Cells. 8:11402019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang L, Chen HY, Hao NB, Tang B, Guo H,
Yong X, Dong H and Yang SM: microRNA inhibitors: Natural and
artificial sequestration of microRNA. Cancer Lett. 407:139–147.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abels ER, Maas SL, Nieland L, Wei Z, Cheah
PS, Tai E, Kolsteeg CJ, Dusoswa SA, Ting DT, Hickman S, et al:
Glioblastoma-associated microglia reprogramming is mediated by
functional transfer of extracellular miR-21. Cell Rep.
28:3105–3119.e7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ouyang H, Gore J, Deitz S and Korc M:
Erratum: microRNA-10b enhances pancreatic cancer cell invasion by
suppressing TIP30 expression and promoting EGF and TGF-β actions.
Oncogene. 36:4952. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye J, Yao Y, Song Q, Li S, Hu Z, Yu Y, Hu
C, Da X, Li H, Chen Q and Wang QK: Up-regulation of miR-95-3p in
hepatocellular carcinoma promotes tumorigenesis by targeting p21
expression. Sci Rep. 6:340342016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma
LN, Xu SL, Yang L, Wang QL, Dang WQ, et al: Oncogenic miR-20a and
miR-106a enhance the invasiveness of human glioma stem cells by
directly targeting TIMP-2. Oncogene. 34:1407–1419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan T, Ooi WF, Qamra A, Cheung A, Ma D,
Sundaram GM, Xu C, Xing M, Poon L, Wang J, et al: HoxC5 and
miR-615-3p target newly evolved genomic regions to repress hTERT
and inhibit tumorigenesis. Nat Commun. 9:1002018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bayraktar R and Van Roosbroeck K: miR-155
in cancer drug resistance and as target for miRNA-based
therapeutics. Cancer Metastasis Rev. 37:33–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyoshi H, Blömer U, Takahashi M, Gage FH
and Verma IM: Development of a self-inactivating lentivirus vector.
J Virol. 72:8150–8157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luan W, Zhou Z, Ni X, Xia Y, Wang J, Yan Y
and Xu B: Long non-coding RNA H19 promotes glucose metabolism and
cell growth in malignant melanoma via miR-106a-5p/E2F3 axis. J
Cancer Res Clin Oncol. 144:531–542. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He QY, Wang GC, Zhang H, Tong DK, Ding C,
Liu K, Ji F, Zhu X and Yang S: miR-106a-5p suppresses the
proliferation, migration, and invasion of osteosarcoma cells by
targeting HMGA2. DNA Cell Biol. 35:506–520. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan YJ, Wei LL, Wu XJ, Huo FC, Mou J and
Pei DS: miR-106a-5p inhibits the cell migration and invasion of
renal cell carcinoma through targeting PAK5. Cell Death Dis.
8:e3155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li D, Wang Z, Chen Z, Lin L, Wang Y,
Sailike D, Luo K, Du G, Xiang X and Jiafu GD: MicroRNA-106a-5p
facilitates human glioblastoma cell proliferation and invasion by
targeting adenomatosis polyposis coli protein. Biochem Biophys Res
Commun. 481:245–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hoey C, Ray J, Jeon J, Huang X, Taeb S,
Ylanko J, Andrews DW, Boutros PC and Liu SK: miRNA-106a is a novel
regulator of radiation resistance through targeting LITAF and ATM
in prostate cancer. Mol Oncol. 12:1324–1341. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pencheva N and Tavazoie SF: Control of
metastatic progression by microRNA regulatory networks. Nat Cell
Biol. 15:546–554. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Liu L, Sun Y, Xue Y, Qu J, Pan S,
Li H, Qu H, Wang J and Zhang J: miR-615-3p promotes proliferation
and migration and inhibits apoptosis through its potential target
CELF2 in gastric cancer. Biomed Pharmacother. 101:406–413. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeung YT, Fan S, Lu B, Yin S, Yang S, Nie
W, Wang M, Zhou L, Li T, Li X, et al: CELF2 suppresses non-small
cell lung carcinoma growth by inhibiting the PREX2-PTEN
interaction. Carcinogenesis. 41:377–389. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Madsen CD, Hooper S, Tozluoglu M,
Bruckbauer A, Fletcher G, Erler JT, Bates PA, Thompson B and Sahai
E: STRIPAK components determine mode of cancer cell migration and
metastasis. Nat Cell Biol. 17:68–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan B, Jiao BH, Fan FS, Lu SK, Song J, Guo
CY, Yang JK and Yang L: Downregulation of miR-95-3p inhibits
proliferation, and invasion promoting apoptosis of glioma cells by
targeting CELF2. Int J Oncol. 47:1025–1033. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Piqué L, Martinez de Paz A, Piñeyro D,
Martínez-Cardús A, Castro de Moura M, Llinàs-Arias P, Setien F,
Gomez-Miragaya J, Gonzalez-Suarez E, Sigurdsson S, et al:
Epigenetic inactivation of the splicing RNA-binding protein CELF2
in human breast cancer. Oncogene. 38:7106–7112. 2019. View Article : Google Scholar
|
